Cardiac arrest during treatment of Pneumocystis carinii pneumonia with intravenous pentamidine isethionate

Scand J Infect Dis. 1992;24(1):111-2. doi: 10.3109/00365549209048410.

Abstract

A 27-year-old man, HIV-positive for 4 years, developed ventricular fibrillation and cardiac arrest during treatment of Pneumocystis carinii pneumonia with intravenous pentamidine isethionate. The dosage was 4 mg/kg/day for 18 days. Nephrotoxicity occurred and raised serum potassium. The plasma concentration of pentamidine was 580 nmol/l. Careful monitoring of renal and cardiac functions is recommended during intravenous therapy with pentamidine isethionate.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Heart Arrest / chemically induced*
  • Humans
  • Infusions, Intravenous
  • Kidney Diseases / chemically induced
  • Male
  • Pentamidine / administration & dosage
  • Pentamidine / adverse effects*
  • Pentamidine / blood
  • Pneumonia, Pneumocystis / drug therapy*
  • Potassium / blood

Substances

  • Pentamidine
  • Potassium